171 results
Page 2 of 9
8-K
EX-99.1
99bvt
21 Jul 21
Other Events
5:17pm
425
EX-99.1
5ec16snsfai8ym0i0m
21 Jul 21
Business combination disclosure
5:15pm
425
EX-99.2
zf5mnbtkqznmpwp
21 Jul 21
Business combination disclosure
5:15pm
424B3
dat3wm57 s3o0o3xa0f
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
4ydodrwmmys1
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
S-4
yqr 7jplw2eh5b6ts5k
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
8-K
EX-99.1
m0xxm99qrf00l0bwfce
22 Jun 21
Acasti Pharma Provides Fiscal 2021 Year-End Business Update
7:00am
8-K
EX-99.1
e5odwmae
17 May 21
Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
7:11am
8-K
EX-99.1
zzhcc0 qjdug0sxcal
7 May 21
Entry into a Material Definitive Agreement
7:09am
425
EX-99.1
jbe97ogbhm8rti ibrnc
7 May 21
Business combination disclosure
7:08am
8-K
EX-99.1
f7v0b
9 Mar 21
Acasti Pharma Provides Update on Recent Financing Activities
12:00am
8-K
EX-99.1
0rfu1xf g2eseipb0
9 Feb 21
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
4:35pm
8-K
EX-99.1
507yqq
27 Jan 21
Acasti Pharma Provides Update on Recent Financing Activities
7:35am
8-K
EX-99.1
4sf16ays6i d77h
16 Nov 20
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021
7:05am
10-Q
e6zn8e
13 Aug 20
Quarterly report
8:30am
8-K
EX-99.1
pzoq63rx
13 Aug 20
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021
8:30am
8-K
EX-99.1
1qfletihrb9w63hc
31 Jul 20
Regulation FD Disclosure
4:05pm